Net loss on a GAAP basis was $11,900,000 or $0.26 per share compared to a net loss $13,000,000 or $0.29 per share for the Q3 of 2022. Adjusted EBITDA was a negative $1,900,000 Q3 of 2023 compared to cash used for operations of $2,800,000 for the Q3 of 2020 Cash provided by operations included a $10,800,000 decrease in accounts receivable and a $3,300,000 decrease In inventory, net capital expenditures were $2,700,000 for the Q3 of 2023 $4,400,000 year to date, Compared to $3,500,000 for the Q3 of 2022 $16,400,000 for the 1st 3 quarters of 2020 As discussed last quarter, overall CapEx in 2023 will be down significantly year over year. Turning to the balance sheet. Our balance sheet remains strong as we ended the Q3 with total cash, cash equivalents, restricted cash and investments of $111,800,000 and no debt. Total cash and investments increased by approximately $10,000,000 from last quarter and by $3,400,000 since the end of 2022.